Therefore, the aim of this research was to investigate whether tumour PSMA expression, calculated as SUVmax, on PSMA PET/CT for staging PCa contributes to the preoperative and postoperative predictions of BCR occurrence after curative treatment. The gene discussed is FOLH1; the disease is neoplasm.